Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 130

1.

Deep Learning-Based Quantification of PET/CT Prostate Gland Uptake: Association with Overall Survival.

Polymeri E, Sadik M, Kaboteh R, Borrelli P, Enqvist O, Ulén J, Ohlsson M, Trägårdh E, Poulsen MH, Simonsen JA, Flemming Hoilund-Carlsen P, Johnsson ÅA, Edenbrandt L.

Clin Physiol Funct Imaging. 2019 Dec 3. doi: 10.1111/cpf.12611. [Epub ahead of print]

PMID:
31794112
2.

18F-sodium fluoride PET/CT provides prognostic clarity compared to calcium and Framingham risk scoring when addressing whole-heart arterial calcification.

Sorci O, Batzdorf AS, Mayer M, Rhodes S, Peng M, Jankelovits AR, Hornyak JN, Gerke O, Høilund-Carlsen PF, Alavi A, Rajapakse CS.

Eur J Nucl Med Mol Imaging. 2019 Nov 16. doi: 10.1007/s00259-019-04590-3. [Epub ahead of print]

PMID:
31734781
3.

Comparison of methods of quantifying global synovial metabolic activity with FDG-PET/CT in rheumatoid arthritis.

Raynor WY, Jonnakuti VS, Zirakchian Zadeh M, Werner TJ, Cheng G, Zhuang H, Høilund-Carlsen PF, Alavi A, Baker JF.

Int J Rheum Dis. 2019 Dec;22(12):2191-2198. doi: 10.1111/1756-185X.13730. Epub 2019 Nov 13.

PMID:
31721461
4.

Suboptimal validity of amyloid imaging-based diagnosis and management of Alzheimer's disease: why it is time to abandon the approach.

Alavi A, Barrio JR, Werner TJ, Khosravi M, Newberg A, Høilund-Carlsen PF.

Eur J Nucl Med Mol Imaging. 2019 Oct 31. doi: 10.1007/s00259-019-04564-5. [Epub ahead of print] No abstract available.

PMID:
31673787
5.

18F-Fluoromethylcholine-positron emission tomography/computed tomography for diagnosing bone and lymph node metastases in patients with intermediate- or high-risk prostate cancer.

Mortensen MA, Poulsen MH, Gerke O, Jakobsen JS, Høilund-Carlsen PF, Lund L.

Prostate Int. 2019 Sep;7(3):119-123. doi: 10.1016/j.prnil.2019.01.002. Epub 2019 Jan 19.

6.

An update on the unparalleled impact of FDG-PET imaging on the day-to-day practice of medicine with emphasis on management of infectious/inflammatory disorders.

Alavi A, Hess S, Werner TJ, Høilund-Carlsen PF.

Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):18-27. doi: 10.1007/s00259-019-04490-6. Epub 2019 Sep 4. No abstract available.

PMID:
31482427
7.

FDG-PET/CT Versus Contrast-Enhanced CT for Response Evaluation in Metastatic Breast Cancer: A Systematic Review.

Helland F, Hallin Henriksen M, Gerke O, Vogsen M, Høilund-Carlsen PF, Hildebrandt MG.

Diagnostics (Basel). 2019 Aug 27;9(3). pii: E106. doi: 10.3390/diagnostics9030106. Review.

8.

FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: Today, Tomorrow, and Beyond.

Hildebrandt MG, Lauridsen JF, Vogsen M, Holm J, Vilstrup MH, Braad PE, Gerke O, Thomassen M, Ewertz M, Høilund-Carlsen PF; Centre for Personalized Response Monitoring in Oncology (PREMIO).

Cancers (Basel). 2019 Aug 15;11(8). pii: E1190. doi: 10.3390/cancers11081190.

9.

Does therapy of the primary tumor matter in oligometastatic prostate cancer? A prospective 10-year follow-up study.

Poulsen MH, Jakobsen JS, Mortensen MA, Høilund-Carlsen PF, Lund L.

Res Rep Urol. 2019 Jul 30;11:215-221. doi: 10.2147/RRU.S190140. eCollection 2019.

10.

Artificial intelligence-based versus manual assessment of prostate cancer in the prostate gland: a method comparison study.

Mortensen MA, Borrelli P, Poulsen MH, Gerke O, Enqvist O, Ulén J, Trägårdh E, Constantinescu C, Edenbrandt L, Lund L, Høilund-Carlsen PF.

Clin Physiol Funct Imaging. 2019 Nov;39(6):399-406. doi: 10.1111/cpf.12592. Epub 2019 Sep 8.

PMID:
31436365
11.

Hybrid PET/MRI in major cancers: a scoping review.

Morsing A, Hildebrandt MG, Vilstrup MH, Wallenius SE, Gerke O, Petersen H, Johansen A, Andersen TL, Høilund-Carlsen PF.

Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2138-2151. doi: 10.1007/s00259-019-04402-8. Epub 2019 Jul 2.

PMID:
31267161
12.

Upfront PET/CT affects management decisions in patients with recurrent head and neck squamous cell carcinoma.

Rohde M, Nielsen AL, Johansen J, Sørensen JA, Diaz A, Pareek M, Asmussen JT, Gerke O, Thomassen A, Gyldenkerne N, Døssing H, Bjørndal K, Høilund-Carlsen PF, Godballe C.

Oral Oncol. 2019 Jul;94:1-7. doi: 10.1016/j.oraloncology.2019.04.025. Epub 2019 May 6.

PMID:
31178202
13.

Up-front F18-FDG PET/CT in suspected salivary gland carcinoma.

Westergaard-Nielsen M, Rohde M, Godballe C, Eriksen JG, Larsen SR, Gerke O, Nguyen N, Nielsen MK, Nielsen AL, Thomassen A, Asmussen JT, Diaz A, Høilund-Carlsen PF, Bjørndal K.

Ann Nucl Med. 2019 Aug;33(8):554-563. doi: 10.1007/s12149-019-01362-9. Epub 2019 May 17.

PMID:
31102059
14.

PET/CT-Based Response Evaluation in Cancer-a Systematic Review of Design Issues.

Gerke O, Ehlers K, Motschall E, Høilund-Carlsen PF, Vach W.

Mol Imaging Biol. 2019 Apr 23. doi: 10.1007/s11307-019-01351-4. [Epub ahead of print]

PMID:
31016638
15.

PET-CT-MR Imaging-Based Cardiovascular Imaging.

Høilund-Carlsen PF, Alavi A, Moghbel MC, Salavati A.

PET Clin. 2019 Apr;14(2):xiii-xv. doi: 10.1016/j.cpet.2019.01.001. No abstract available.

PMID:
30826027
16.

Evolving Role of PET in Detecting and Characterizing Atherosclerosis.

Høilund-Carlsen PF, Moghbel MC, Gerke O, Alavi A.

PET Clin. 2019 Apr;14(2):197-209. doi: 10.1016/j.cpet.2018.12.001. Review.

PMID:
30826018
17.

Diagnostic manifestations of total hemispheric glucose metabolism ratio in neuronal network diaschisis: diagnostic implications in Alzheimer's disease and mild cognitive impairment.

Segtnan EA, Majdi A, Constantinescu C, Grupe P, Gerke O, Dali HÍ, Strøm OE, Holm J, Alavi A, Sadigh-Eteghad S, Wermuth L, Hildebrandt MG, Gjedde A, Høilund-Carlsen PF.

Eur J Nucl Med Mol Imaging. 2019 May;46(5):1164-1174. doi: 10.1007/s00259-018-4248-0. Epub 2019 Jan 12.

PMID:
30637500
18.

Clinical value of 18F-FDG-PET/CT in suspected serious disease with special emphasis on occult cancer.

Caspersen KB, Giannoutsou N, Gerke O, Alavi A, Høilund-Carlsen PF, Hess S.

Ann Nucl Med. 2019 Mar;33(3):184-192. doi: 10.1007/s12149-018-01322-9. Epub 2018 Dec 19.

PMID:
30569441
19.

A prospective study on dual time 18F-FDG-PET/CT in high-risk prostate cancer patients.

Mortensen MA, Vilstrup MH, Poulsen MH, Gerke O, Høilund-Carlsen PF, Lund L.

BMC Res Notes. 2018 Dec 7;11(1):871. doi: 10.1186/s13104-018-3985-2.

20.

The Role of PET in Evaluating Atherosclerosis: A Critical Review.

Moghbel M, Al-Zaghal A, Werner TJ, Constantinescu CM, Høilund-Carlsen PF, Alavi A.

Semin Nucl Med. 2018 Nov;48(6):488-497. doi: 10.1053/j.semnuclmed.2018.07.001. Epub 2018 Aug 30. Review.

PMID:
30322475

Supplemental Content

Loading ...
Support Center